Status:
TERMINATED
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Lead Sponsor:
Duke University
Collaborating Sponsors:
Janssen, LP
Conditions:
Schizophrenia
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive fu...
Detailed Description
First episode patients have a greater potential for therapeutic response than multi-episode patients, and many of them also havea great desire to rejoin the workforce. Unfortunately, first episode pat...
Eligibility Criteria
Inclusion
- male or female between 18-40 years of age
- meet DSM-IV criteria for first-episode schizophreniform, schizophrenia or schizoaffective disorder
Exclusion
- pregnant \& breast-feeding women
- patients with known sensitivity to oral Risperdal
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00314613
Start Date
April 1 2006
Last Update
December 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
John Umstead Hospital
Butner, North Carolina, United States, 27509
2
Duke University Medical Center
Durham, North Carolina, United States, 27710